Clinical Trial Update: Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial of Mesenchymal Trophic Factor (MTF) for osteoarthritis of the knee in Phase 1/Phase 2 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Mesenchymal Trophic Factor

Snippet

Sponsor: Translational Biosciences | Conditions: Osteoarthritis of the Knee | Phase 1, Phase 2 | Status: WITHDRAWN